Back to User profile » Dr Kai-Michael Beeh

Papers published by Dr Kai-Michael Beeh:

Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany

Beeh KM, Rothnie KJ, Claussen J, Hardtstock F, Knapp RK, Wilke T, Czira A, Compton C, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:945-956

Published Date: 17 April 2024

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

Halpin DM, Kendall R, Shukla S, Martin A, Shah D, Midwinter D, Beeh KM, Kocks JWH, Jones PW, Compton C, Risebrough NA, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2745-2755

Published Date: 25 October 2022

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes

Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P

Pragmatic and Observational Research 2021, 12:25-35

Published Date: 24 May 2021

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

Watz H, Troosters T, Beeh KM, Garcia-Aymerich J, Paggiaro P, Molins E, Notari M, Zapata A, Jarreta D, Garcia Gil E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2545-2558

Published Date: 24 August 2017

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

Marin JM, Beeh KM, Clemens A, Castellani W, Schaper L, Saralaya D, Gunstone A, Casamor R, Kostikas K, Aalamian-Mattheis M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1425-1434

Published Date: 28 June 2016

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Kai M Beeh, Jutta Beier

Core Evidence 2009, 4:37-41

Published Date: 18 June 2009